BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 34572770)

  • 1. Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments.
    Gómez-Cebrián N; Domingo-Ortí I; Poveda JL; Vicent MJ; Puchades-Carrasco L; Pineda-Lucena A
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.
    Gómez-Cebrián N; Poveda JL; Pineda-Lucena A; Puchades-Carrasco L
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omics-Based Investigations of Breast Cancer.
    Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging and the completion of the omics paradigm in breast cancer.
    Leithner D; Horvat JV; Ochoa-Albiztegui RE; Thakur S; Wengert G; Morris EA; Helbich TH; Pinker K
    Radiologe; 2018 Nov; 58(Suppl 1):7-13. PubMed ID: 29947931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omics Technologies Improving Breast Cancer Research and Diagnostics.
    Orsini A; Diquigiovanni C; Bonora E
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A scoping review and proposed workflow for multi-omic rare disease research.
    Kerr K; McAneney H; Smyth LJ; Bailie C; McKee S; McKnight AJ
    Orphanet J Rare Dis; 2020 Apr; 15(1):107. PubMed ID: 32345347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases.
    Sun YV; Hu YJ
    Adv Genet; 2016; 93():147-90. PubMed ID: 26915271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering metabolic rewiring in breast cancer subtypes.
    Ogrodzinski MP; Bernard JJ; Lunt SY
    Transl Res; 2017 Nov; 189():105-122. PubMed ID: 28774752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis.
    Menyhárt O; Győrffy B
    Comput Struct Biotechnol J; 2021; 19():949-960. PubMed ID: 33613862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
    Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
    BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.
    Fleisher B; Brown AN; Ait-Oudhia S
    Pharmacol Res; 2017 Oct; 124():20-33. PubMed ID: 28735000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and Metabolic Subtypes in Sporadic and Inherited Clear Cell Renal Cell Carcinoma.
    Czyzyk-Krzeska MF; Landero Figueroa JA; Gulati S; Cunningham JT; Meller J; ShamsaeI B; Vemuri B; Plas DR
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33803184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer.
    Nevedomskaya E; Haendler B
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-omic analysis of dysregulated pathways in triple negative breast cancer.
    Sajjad F; Jalal A; Jalal A; Gul Z; Mubeen H; Rizvi SZ; Un-Nisa EA; Asghar A; Butool F
    Asia Pac J Clin Oncol; 2024 Jun; ():. PubMed ID: 38899578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying biomarkers for predicting successful embryo implantation: applying single to multi-OMICs to improve reproductive outcomes.
    Hernández-Vargas P; Muñoz M; Domínguez F
    Hum Reprod Update; 2020 Feb; 26(2):264-301. PubMed ID: 32096829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiomics insights on the onset, progression, and metastatic evolution of breast cancer.
    Alvarez-Frutos L; Barriuso D; Duran M; Infante M; Kroemer G; Palacios-Ramirez R; Senovilla L
    Front Oncol; 2023; 13():1292046. PubMed ID: 38169859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Cell Multi-Omics and Its Prospective Application in Cancer Biology.
    Peng A; Mao X; Zhong J; Fan S; Hu Y
    Proteomics; 2020 Jul; 20(13):e1900271. PubMed ID: 32223079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-omic data integration and analysis using systems genomics approaches: methods and applications in animal production, health and welfare.
    Suravajhala P; Kogelman LJ; Kadarmideen HN
    Genet Sel Evol; 2016 Apr; 48(1):38. PubMed ID: 27130220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Omics Characterization of Tumor Microenvironment Heterogeneity and Immunotherapy Resistance Through Cell States-Based Subtyping in Bladder Cancer.
    Hu R; Tao T; Yu L; Ding Q; Zhu G; Peng G; Zheng S; Yang L; Wu S
    Front Cell Dev Biol; 2021; 9():809588. PubMed ID: 35223867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.